1. Home
  2. Stocks
  3. Novartind Share Price

Novartis India Share Price

Small Cap

₹1,077.70 +7.35 (0.69%)

05 Nov, 2024 20:51

SIP TrendupStart SIP in NOVARTIND

Start SIP
Performance Financial Technical Events FnO Shareholding Pattern More FAQ’s

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume

Investment Returns

  • Over 1 Month + 1.3%
  • Over 3 Month -5.1%
  • Over 6 Month + 1.93%
  • Over 1 Year + 65.14%
SIP Lightning

Smart Investing Starts Here Start SIP with Novartis India for Steady Growth!

Novartis India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 30.4
  • PEG Ratio
  • 2.2
  • Market Cap Cr
  • 2,661
  • P/B Ratio
  • 3.6
  • Average True Range
  • 35.66
  • EPS
  • 33.7
  • Dividend Yield
  • 2.3
  • MACD Signal
  • -6.2
  • RSI
  • 50.68
  • MFI
  • 52.7

Novartis India Financial

Novartis India Technicals

EMA & SMA

Current Price
₹1,077.70
+ 7.35 (0.69%)
pointer
  • stock-down_img
  • Bullish Moving Average 11
  • stock-up_img
  • Bearish Moving Average 5
  • 20 Day
  • ₹1,070.79
  • 50 Day
  • ₹1,081.45
  • 100 Day
  • ₹1,078.83
  • 200 Day
  • ₹1,029.28

Resistance and Support

1077.32 Pivot Speed
  • R3 1,127.43
  • R2 1,111.22
  • R1 1,093.53
  • S1 1,059.63
  • S2 1,043.42
  • S3 1,025.73

Is Novartis India Worth Buying?

BUY SELL HOLD

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Novartis is a global healthcare company based in Switzerland, specializing in innovative pharmaceuticals and generics. The company focuses on research and development to deliver effective treatments across various therapeutic areas, including oncology, cardiology, and neuroscience, improving patient outcomes worldwide. Novartis India has an operating revenue of Rs. 345.10 Cr. on a trailing 12-month basis. An annual revenue de-growth of -9% needs improvement, Pre-tax margin of 37% is great, ROE of 11% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -13% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 28 which is a POOR score indicating inconsistency in earnings, a RS Rating of 52 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 35 indicates it belongs to a strong industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Novartis India Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-25 Quarterly Results
2024-05-10 Audited Results & Final Dividend
2024-01-25 Quarterly Results
2023-10-27 Quarterly Results
2023-07-26 Quarterly Results

Novartis India F&O

Novartis India Shareholding Pattern

70.68%
0%
0.51%
0.19%
0.01%
23.05%
5.56%
  • NSE Symbol
  • NOVARTIND
  • BSE Symbol
  • 500672
  • ISIN
  • INE234A01025

Novartis India FAQs

Novartis India share price is ₹1,077 As on 05 November, 2024 | 20:37

The Market Cap of Novartis India is ₹2660.9 Cr As on 05 November, 2024 | 20:37

The P/E ratio of Novartis India is 30.4 As on 05 November, 2024 | 20:37

The PB ratio of Novartis India is 3.6 As on 05 November, 2024 | 20:37

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

The Vigilance Awareness Week for the year 2024 (VAW 2024) would be observed from October 28, 2024 to November 03, 2024
“सत्यनिष्ठा की संस्कृनि सेराष्र की समद्ृधि” “Culture of Integrity for Nation's Prosperity”
e-pledge link (https://pledge.cvc.nic.in/)

5paisa Capital Ltd. CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

*Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

Contact Us

Attention Investors

  • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
  • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Email: support@5paisa.com

Support Desk Helpline: 8976689766

©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.